{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-053124","form_type":"8-K","ticker":"DHR","cik":"0000313616","company_name":"DANAHER CORP /DE/","filed_at":"2026-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.339886+00:00","generated_at":"2026-05-16T02:36:24.283082+00:00","sec_items":["8.01","5.02","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Danaher to acquire Masimo for $180/share cash, ~$9.9B enterprise value","bullets":["All-cash deal at $180/share; total enterprise value ~$9.9B including assumed debt.","Represents ~18x estimated 2027 EBITDA, or 15x including full annual synergies.","Masimo to operate as standalone company within Danaher's Diagnostics segment.","Expected to close H2 2026; subject to Masimo shareholder and regulatory approvals.","Expects $125M annual cost synergies and >$50M revenue synergies by year 5; EPS accretive $0.15–0.20 first year."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-053124","json":"https://secwatch.observer/filing/0001193125-26-053124.json","markdown":"https://secwatch.observer/filing/0001193125-26-053124.md","text":"https://secwatch.observer/filing/0001193125-26-053124.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313616/000119312526053124/0001193125-26-053124-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313616/000119312526053124/d110495d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:36:24.283082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}